Search Results for “Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking” – Page 32

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper

Braido, F.+, Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Gerth van Wijk, R., La Grutta, S., Lombardi, C., Maurer, M. Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Todo Bom, A., Bousquet, J., Zuberbier, T., and Baiardini, I.: Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper. Allergy 2010: 65; 959-968. IF: 6.29

o.099

111.	Maurer, M., Church, M. K., Marsland, A. M., Sussman, G., Siebenhaar, F., Vestergaard, C., and Broom, B.: Questions and answers in chronic urticaria: where do we stand and where do we go? J. Eur. Acad. Dermatol. Venereol. 2016: 30, Suppl. 5; 7-15. IF: 3.52

r.111

105.	Maurer, M., Vena, G. A., Cassano, N., and Zuberbier, T.: Current and future therapies for treating chronic spontaneous urticaria. Expert Opin. Pharmacother. 2016: 17; 1131-1139. IF: 3.89

r.105

99.	Weller, K., Zuberbier, T., and Maurer, M.: Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr. Opin. Allergy Clin. Immunol. 2015: 15; 220-226. IF: 2.77

r.099

85.	Maurer, M.: Urticaria and angioedema. History of allergy. Chem. Immunol. Allergy 2014: 100, 101-104. IF N/A

EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis

422.

Agache, I.⁺, Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger T., Eyerich, K. Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P. Y., O’Mahony, L., Schwarze, J., Warner, A., Werfel, T., Palomares, O., and Jutel, M.: EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy 2021: 76; 988-1009. IF: 14.71

o.422

76.	Maurer, M., Magerl, M., Metz, M., Weller, K., and Siebenhaar, F.: Miltefosine: A novel treatment option for mast cell-mediated diseases. J. Dermatol. Treat. 2013: 24; 244-249. IF: 1.76

103.	Kolkhir, P., Balakirski, G., Merk, H. F., Olisova, O., and Maurer, M.+: Chronic spontaneous urticaria and internal parasites – a systematic review. Allergy 2016: 71; 308-322. IF: 7.36

61	Siebenhaar, F., Magerl, M., Peters, E. M. J., Hendrix, S., Metz, M., and Maurer, M.+: Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J. Allergy Clin. Immunol. 2008: 121; 955-961. IF: 9.77

58.	Weller, K., Soost, S., Worm, M., Maurer, M., and Zuberbier, T.: Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist? J. Dtsch. Dermatol. Ges. 2012: 10; 221-239. IF: 1.40

Results

Search Results for: Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking – Page 32

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper

Questions and answers in chronic urticaria: where do we stand and where do we go?

Current and future therapies for treating chronic spontaneous urticaria

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

Urticaria and angioedema

EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis

A novel treatment option for mast cell-mediated diseases

Chronic spontaneous urticaria and internal parasites – a systematic review

Mast cell–driven skin inflammation is impaired in the absence of sensory nerves

Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist?